Table 1.
Laboratory analysis and period of follow-up of the included studies in our systematic review.
| First Author | Study Design | Number of Cases | Bartter Syndrome Type | Laboratory Evaluation | Period of Follow-Up | ||||
|---|---|---|---|---|---|---|---|---|---|
| Hypokalemia | Hyponatremia | Hyperreninemia | Metabolic Alkalosis | Hyperaldosteronism | |||||
| Abdelgadir et al. [10] | CR | 1 | Type Ⅲ | Y | Y | Y | |||
| Adachi et al. [11] | CR | 1 | Type III | Y | - | Y | Y | Y | 14 yr |
| Afzal et al. [12] | CR | 1 | Type I | Y | Y | Y | Y | Y | |
| Agrawal et al. [13] | CR | 1 | Type III | Y | Y | Y | 1 mth | ||
| Akuma et al. [14] | CR | 1 | Type Ⅱ | Y | N | Y | |||
| Alasfour et al. [15] | CR | 1 | Type I | Y | Y | N | Y | ||
| Alhammadi et al. [16] | CR | 1 | Type I | Y | Y | ||||
| Chiang et al. [17] | CR | 1 | Type Ⅲ | Y | Y | Y | |||
| Cho et al. [18] | CR | 1 | Type III | Y | Y | ||||
| Chuang et al. [19] | CR | 1 | Type I | Y | Y | ||||
| Coroado et al. [20] | CR | 1 | Type Ⅳ | 7 mth | |||||
| Cruz et al. [21] | CR | 1 | Type Ⅲ | Y | N | Y | Y | Y | 2 yr |
| Fretzayas et al. [22] | CR | 1 | Type Ⅱ | Y | Y | Y | Y | Y | 3 yr |
| Gargano et al. [23] | CR | 1 | Type III | Y | Y | - | Y | 1 yr | |
| Gollasch et al. [24] | CR | 1 | Type Ⅱ | Y | Y | Y | 3 yr | ||
| Gross et al. [25] | CR | 1 | Type I | N | N | N | 10 mth | ||
| Hegde et al. [26] | CR | 1 | Type I | Y | Y | Y | Y | ||
| Heilberg et al. [27] | CR | 1 | Type Ⅳ | Y | Y | Y | 2 w | ||
| Huang et al. [28] | CR | 1 | Type Ⅱ | Y | N | Y | Y | Y | 1 yr |
| Hussain et al. [29] | CR | 1 | Type Ⅴ | Y | Y | Y | 3 mth | ||
| Khan et al. [30] | CR | 1 | Y | Y | Y | ||||
| Khandelwal et al. [31] | CR | 1 | Type Ⅱ | N | N | N | N | N | |
| Le et al. [32] | CR | 1 | Type Ⅲ | Y | Y | Y | Y | ||
| Li et al. [33] | CR | 1 | Type I | ||||||
| Mali et al. [34] | CR | 1 | Type Ⅲ | Y | Y | Y | Y | ||
| Mani et al. [35] | CR | 1 | Type Ⅱ | N | Y | Y | Y | Y | 5 mth |
| Maruyama et al. [36] | CR | 1 | Type I | Y | Y | Y | 7 mth | ||
| Mou et al. [37] | CR | 1 | Type Ⅲ | Y | Y | Y | 2.9 yr | ||
| Nam et al. [38] | CR | 1 | Type I | Y | Y | Y | N | Y | 3 mth |
| Ozdemir et al. [39] | CR | 1 | Y | Y | Y | Y | Y | ||
| Özdemir et al. [40] | CR | 1 | - | Y | Y | - | Y | - | |
| Pablos et al. [41] | CR | 1 | Type Ⅳ | Y | Y | Y | Y | 2 yr | |
| Plumb et al. [42] | CR | 1 | Type Ⅳ | Y | Y | 1 yr | |||
| Preshaw et al. [43] | CR | 1 | Type I | Y | 2 yr | ||||
| Rachid et al. [44] | CR | 1 | Type I | ||||||
| Raza et al. [45] | CR | 1 | Y | 2 mth | |||||
| Sakallı et al. [46] | CR | 1 | Type Ⅳ | Y | Y | Y | Y | Y | 16 mth |
| Sobash et al. [47] | CR | 1 | Y | 1 mth | |||||
| Soumya et al. [48] | CR | 1 | Y | Y | Y | Y | |||
| Vergine et al. [49] | CR | 1 | Type I | Y | 1.5 yr | ||||
| Verma et al. [50] | CR | 1 | Y | Y | Y | Y | 3 mth | ||
| Vieira et al. [51] | CR | 1 | Type Ⅲ | Y | Y | Y | Y | Y | 1 yr |
| Wang et al. [52] | CR | 1 | Type Ⅳ | Y | 2 yr | ||||
| Westland et al. [53] | CR | 1 | Type Ⅲ | Y | Y | Y | - | ||
| Wu et al. [54] | CR | 1 | Type III | Y | Y | Y | 10 yr | ||
| Yaqub et al. [55] | CR | 1 | Y | Y | Y | Y | 1 mth | ||
| Yoshioka et al. [56] | CR | 1 | Y | Y | Y | Y | 12 d | ||
| Zhu et al. [57] | CR | 1 | Type III | Y | Y | Y | Y | 14 yr | |
| Azzi et al. [58] | CS | 1/7 | Type Ⅲ | Y | 4 w | ||||
| 2/7 | Type Ⅳ | Y | 4 w | ||||||
| 3/7 | Type I | 4 w | |||||||
| 4/7 | 4 w | ||||||||
| 5/7 | Type Ⅱ | 4 w | |||||||
| 6/7 | Type Ⅱ | 4 w | |||||||
| 7/7 | Type I | 4 w | |||||||
| Buyukcelik et al. [59] | CS | 1/3 | Y | Y | Y | Y | Y | 12 yr | |
| 2/3 | Y | Y | Y | Y | Y | 2 yr | |||
| 3/3 | Y | Y | Y | Y | Y | 11 yr | |||
| Çetinkaya et al. [60] | CS | 1/2 | Y | Y | Y | Y | Y | - | |
| 2/2 | Y | - | |||||||
| Han et al. [61] | CS | 42 | Type Ⅲ | Y (39/42) | Y (27/42) | Y (33/35) | Y (39/42) | Y (33/35) | 21 mth 9–38 mth (36/42) |
| Hussain et al. [62] | CS | 1/2 | Y | Y | Y | Y | Y | 9 mth | |
| 2/2 | Y | Y | Y | Y | Y | 2 mth | |||
| London et al. [63] | CS | 1/5(V-8) | Type Ⅱ | Y | Y | Y | 7 yr | ||
| 2/5(V-10) | Type Ⅱ | Y | 20 yr | ||||||
| 3/5(V-11) | Type Ⅱ | Y | Y | Y | 28 yr | ||||
| 4/5(V-3) | Type Ⅱ | 7 yr | |||||||
| 5/5(V-4) | Type Ⅱ | Y | Y | Y | 9 yr | ||||
| Sharma et al. [64] | CS | 1/2 | Type Ⅱ | Y | Y | Y | Y | Y | - |
| 2/2 | Type I | Y | Y | Y | Y | Y | - | ||
| Yang et al. [65] | CS | 1/2 | Type Ⅲ | Y | Y | Y | Y | Y | 6 yr |
| 2/2 | Type Ⅲ | Y | Y | Y | Y | Y | 2 yr | ||
| Zuo et al. [66] | CS | 1/5 | Type Ⅱ | Y | 2.58 yr | ||||
| 2/5 | Type Ⅱ | N | 3.5 yr | ||||||
| 3/5 | Type Ⅱ | Y | 0.5 yr | ||||||
| 4/5 | Type Ⅱ | N | 1 yr | ||||||
| 5/5 | Type Ⅱ | N | 1.83 yr | ||||||
d, Day(s); w, week(s); mth, month(s); yr, year(s); Y, Yes; N, No; CR, Case Report; CS, Case Series.